Oncology Pharma & Biotech Research & Innovation Xenothera: innovative antibodies for new perspectives in the fight against cancer
Oncology Research & Innovation Paris Kids Cancer, the new crossroads for pediatric oncology experts in the Paris region
Hospital Oncology Research & Innovation Hôpital Saint-Louis AP-HP: 50 years at the forefront of allogeneicbone marrow transplantation
France's attractiveness Oncology Research & Innovation France Internationally Recognized During Pink October
MedTech Oncology Research & Innovation Guerbet takes a majority stake in Intrasense thus becoming a major actor in AI applied to medical imaging
Oncology Pharma & Biotech Research & Innovation TCR knockout, Promega's new bioluminescence-based “gene reporter” cell assay technology platform
France's attractiveness Oncology Research & Innovation The Paris Saclay Cancer Cluster and MATWIN join forces to accelerate innovation in the fight against cancer
Digital health Oncology Pharma & Biotech TISSIUM raises €50 million in a Series D round of financing for its biopolymer platform for tissue reconstruction
Awards & Rankings Infectious diseases Oncology The five winners of the Call for Expressions of Interest (AMI) for the UNIBASE program are unveiled
Artificial Intelligence France's attractiveness Oncology Owkin launches PortrAIt, in collaboration with Gustave Roussy
Covid-19 Digital health Oncology Healthcare infrastructures Business Seminar organized in Romania and Poland by Business France and French Healthcare
Awards & Rankings France's attractiveness Oncology Transgene and BioInvent win JITC (Journal for ImmunoTherapy of Cancer) award
France's attractiveness Hospital Oncology Pink October - the Institut Curie, leading cancer treatment center in Europe
France's attractiveness Oncology Research & Innovation Neolys Diagnostics detects radiosensitive patients
France's attractiveness Oncology Research & Innovation ASCO 2022 - France honored at the World Cancer Congress
France's attractiveness Oncology Pharma & Biotech Innate Pharma is working with AstraZeneca to speed up the development of its flagship molecule - “monalizumab”
France's attractiveness Hospital Oncology Will France soon have the world's largest cluster dedicated to oncology?
